Doxazosin, a Classic Alpha 1-Adrenoceptor Antagonist, Overcomes Osimertinib Resistance in Cancer Cells via the Upregulation of Autophagy as Drug Repurposing
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Doxazosin, a Classic Alpha 1-Adrenoceptor Antagonist, Overcomes Osimertinib Resistance in Cancer Cells via the Upregulation of Autophagy as Drug Repurposing
Authors
Keywords
-
Journal
Biomedicines
Volume 8, Issue 8, Pages 273
Publisher
MDPI AG
Online
2020-08-05
DOI
10.3390/biomedicines8080273
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Autophagy and autophagy-related proteins in cancer
- (2020) Xiaohua Li et al. Molecular Cancer
- Protective autophagy decreases osimertinib cytotoxicity through regulation of stem cell-like properties in lung cancer
- (2019) Li Li et al. CANCER LETTERS
- Gossypol overcomes EGFR-TKIs resistance in non-small cell lung cancer cells by targeting YAP/TAZ and EGFRL858R/T790M
- (2019) Jian Xu et al. BIOMEDICINE & PHARMACOTHERAPY
- Curcumin overcome primary gefitinib resistance in non-small-cell lung cancer cells through inducing autophagy-related cell death
- (2019) Ping Chen et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Brexpiprazole, a Serotonin-Dopamine Activity Modulator, Can Sensitize Glioma Stem Cells to Osimertinib, a Third-Generation EGFR-TKI, via Survivin Reduction
- (2019) Shuhei Suzuki et al. Cancers
- Brexpiprazole Reduces Survivin and Reverses EGFR Tyrosine Kinase Inhibitor Resistance in Lung and Pancreatic Cancer
- (2019) TOMOMI SANOMACHI et al. ANTICANCER RESEARCH
- Osimertinib resistance in non-small cell lung cancer: Mechanisms and therapeutic strategies
- (2018) Zheng-Hai Tang et al. CANCER LETTERS
- Targeting EGFR-mediated autophagy as a potential strategy for cancer therapy
- (2018) Mopa Alina Sooro et al. INTERNATIONAL JOURNAL OF CANCER
- Osimertinib in Untreated EGFR-Mutated Advanced Non–Small-Cell Lung Cancer
- (2018) Jean-Charles Soria et al. NEW ENGLAND JOURNAL OF MEDICINE
- AZD9291 promotes autophagy and inhibits PI3K/Akt pathway in NSCLC cancer cells
- (2018) Zhirui Zhang et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Involvement of GLUT1-mediated glucose transport and metabolism in gefitinib resistance of non-small-cell lung cancer cells
- (2018) Shuhei Suzuki et al. Oncotarget
- Regulation of selective autophagy: the p62/SQSTM1 paradigm
- (2017) Trond Lamark et al. Essays in Biochemistry
- The Adverse Effect of Hypertension in the Treatment of Thyroid Cancer with Multi-Kinase Inhibitors
- (2017) Ole Ancker et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Pharmacological modulation of autophagy: therapeutic potential and persisting obstacles
- (2017) Lorenzo Galluzzi et al. NATURE REVIEWS DRUG DISCOVERY
- Osimertinib or Platinum–Pemetrexed in EGFR T790M–Positive Lung Cancer
- (2017) Tony S. Mok et al. NEW ENGLAND JOURNAL OF MEDICINE
- Osimertinib induces autophagy and apoptosis via reactive oxygen species generation in non-small cell lung cancer cells
- (2017) Zheng-Hai Tang et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Repositioning CEP-1347, a chemical agent originally developed for the treatment of Parkinson’s disease, as an anti-cancer stem cell drug
- (2017) Masashi Okada et al. Oncotarget
- Aripiprazole, an Antipsychotic and Partial Dopamine Agonist, Inhibits Cancer Stem Cells and Reverses Chemoresistance
- (2016) SHUHEI SUZUKI et al. ANTICANCER RESEARCH
- Relative cytotoxic potencies and cell death mechanisms of α1-adrenoceptor antagonists in prostate cancer cell lines
- (2016) Amanda Forbes et al. PROSTATE
- Should Tyrosine Kinase Inhibitors Be Considered for Advanced Non–Small-Cell Lung Cancer Patients With Wild Type EGFR? Two Systematic Reviews and Meta-Analyses of Randomized Trials
- (2015) Claire L. Vale et al. Clinical Lung Cancer
- JNK suppression of chemotherapeutic agents-induced ROS confers chemoresistance on pancreatic cancer stem cells
- (2015) Shuhei Suzuki et al. Oncotarget
- The combination of irreversible EGFR TKIs and SAHA induces apoptosis and autophagy-mediated cell death to overcome acquired resistance in EGFRT790M-mutated lung cancer
- (2014) Tae-Gul Lee et al. INTERNATIONAL JOURNAL OF CANCER
- EGFR-Mediated Beclin 1 Phosphorylation in Autophagy Suppression, Tumor Progression, and Tumor Chemoresistance
- (2013) Yongjie Wei et al. CELL
- Autophagy-Mediated Tumor Promotion
- (2013) Jessie Yanxiang Guo et al. CELL
- Role of Epidermal Growth Factor Receptor Inhibitors in Epidermal Growth Factor Receptor Wild-Type Non–Small-Cell Lung Cancer
- (2013) Scott A. Laurie et al. JOURNAL OF CLINICAL ONCOLOGY
- The Autophagy Inhibitor Chloroquine Overcomes the Innate Resistance of Wild-Type EGFR Non-Small-Cell Lung Cancer Cells to Erlotinib
- (2013) Yiyu Zou et al. Journal of Thoracic Oncology
- Enhanced autophagy is required for survival in EGFR-independent EGFR-mutant lung adenocarcinoma cells
- (2013) Yuji Sakuma et al. LABORATORY INVESTIGATION
- Specific role of JNK in the maintenance of the tumor-initiating capacity of A549 human non-small cell lung cancer cells
- (2013) MASASHI OKADA et al. ONCOLOGY REPORTS
- Autophagy modulation as a potential therapeutic target for diverse diseases
- (2012) David C. Rubinsztein et al. NATURE REVIEWS DRUG DISCOVERY
- Targeting JNK for therapeutic depletion of stem-like glioblastoma cells
- (2012) Ken-ichiro Matsuda et al. Scientific Reports
- Prazosin induces p53-mediated autophagic cell death in H9C2 cells
- (2011) Yi-Fan Yang et al. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
- The Double-Edged Sword of Autophagy Modulation in Cancer
- (2009) E. White et al. CLINICAL CANCER RESEARCH
- Autophagy in the Pathogenesis of Disease
- (2008) Beth Levine et al. CELL
- Phase I/II Trial of Erlotinib and Temozolomide With Radiation Therapy in the Treatment of Newly Diagnosed Glioblastoma Multiforme: North Central Cancer Treatment Group Study N0177
- (2008) Paul D. Brown et al. JOURNAL OF CLINICAL ONCOLOGY
- The α1-adrenergic receptor antagonist doxazosin inhibits EGFR and NF-κB signalling to induce breast cancer cell apoptosis
- (2007) Hongxiang Hui et al. EUROPEAN JOURNAL OF CANCER
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now